{
  "catalogId": "e2b435cb-e916-49e1-b024-6d4defc7bf79",
  "name": "CABAZITAXEL S.K.",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "169 69 36260 00",
  "treatmentDescriptions": "CABAZITAXEL S.K. is indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel- containing treatment regimen.",
  "termsOfIssue": "Prescription required",
  "form": "concentrate and solvent for solution for infusion",
  "route": "i.v",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "CABAZITAXEL/ML",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "L01CD04",
      "name": "CABAZITAXEL"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "CABAZITAXEL S.K.  40 MG/ML (60 MG/1.5 ML) 1 VIAL",
      "manufacturer": {
        "name": "SK PHARM(KS KIM)",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 1.0,
        "unit": "units"
      },
      "packagingDescription": "VIAL GLASS TYPE I",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "9183",
        "yarpa": "31559",
        "pharmasoft": "23141"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 8464.066681,
        "retailMargin": 10.0,
        "maxRetailPrice": 9310.473349,
        "maxPriceWithVAT": 10986.35855
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:44.283003"
  }
}